These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 28961534

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility.
    Chan MM, Soprano KJ, Weinstein K, Fong D.
    J Cell Physiol; 2006 May; 207(2):389-96. PubMed ID: 16402374
    [Abstract] [Full Text] [Related]

  • 3. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
    Liang K, Ng S, Lee F, Lim J, Chung JE, Lee SS, Kurisawa M.
    Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
    [Abstract] [Full Text] [Related]

  • 4. Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy.
    Chung JE, Tan S, Gao SJ, Yongvongsoontorn N, Kim SH, Lee JH, Choi HS, Yano H, Zhuo L, Kurisawa M, Ying JY.
    Nat Nanotechnol; 2014 Nov; 9(11):907-912. PubMed ID: 25282044
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Self-assembled ternary complexes stabilized with hyaluronic acid-green tea catechin conjugates for targeted gene delivery.
    Liang K, Bae KH, Lee F, Xu K, Chung JE, Gao SJ, Kurisawa M.
    J Control Release; 2016 Mar 28; 226():205-16. PubMed ID: 26855049
    [Abstract] [Full Text] [Related]

  • 9. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
    Mayr C, Wagner A, Neureiter D, Pichler M, Jakab M, Illig R, Berr F, Kiesslich T.
    BMC Complement Altern Med; 2015 Jun 23; 15():194. PubMed ID: 26100134
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A two-pronged anti-leukemic agent based on a hyaluronic acid-green tea catechin conjugate for inducing targeted cell death and terminal differentiation.
    Liang K, Bae KH, Nambu A, Dutta B, Chung JE, Osato M, Kurisawa M.
    Biomater Sci; 2019 Dec 17; 8(1):497-505. PubMed ID: 31761907
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R, Sasaki K, Yoshida K.
    Toxicol In Vitro; 2009 Aug 17; 23(5):834-9. PubMed ID: 19406223
    [Abstract] [Full Text] [Related]

  • 16. The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (-)-epigallocatechin-3-gallate, in oral cells.
    Tao L, Forester SC, Lambert JD.
    Mol Nutr Food Res; 2014 Apr 17; 58(4):665-76. PubMed ID: 24249144
    [Abstract] [Full Text] [Related]

  • 17. Green Tea Catechin-Based Complex Micelles Combined with Doxorubicin to Overcome Cardiotoxicity and Multidrug Resistance.
    Cheng T, Liu J, Ren J, Huang F, Ou H, Ding Y, Zhang Y, Ma R, An Y, Liu J, Shi L.
    Theranostics; 2016 Apr 17; 6(9):1277-92. PubMed ID: 27375779
    [Abstract] [Full Text] [Related]

  • 18. Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target.
    Spinella F, Rosanò L, Decandia S, Di Castro V, Albini A, Elia G, Natali PG, Bagnato A.
    Exp Biol Med (Maywood); 2006 Jun 17; 231(6):1123-7. PubMed ID: 16741061
    [Abstract] [Full Text] [Related]

  • 19. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
    Kazi J, Sen R, Ganguly S, Jha T, Ganguly S, Chatterjee Debnath M.
    Int J Pharm; 2020 Jul 30; 585():119449. PubMed ID: 32464231
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.